BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29049482)

  • 1. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
    Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
    JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
    Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
    Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
    Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
    Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.
    Borgan F; Laurikainen H; Veronese M; Marques TR; Haaparanta-Solin M; Solin O; Dahoun T; Rogdaki M; Salokangas RK; Karukivi M; Di Forti M; Turkheimer F; Hietala J; Howes O;
    JAMA Psychiatry; 2019 Oct; 76(10):1074-1084. PubMed ID: 31268519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
    Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
    Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
    Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
    Howes OD; Williams M; Ibrahim K; Leung G; Egerton A; McGuire PK; Turkheimer F
    Brain; 2013 Nov; 136(Pt 11):3242-51. PubMed ID: 24097339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.
    Dahoun T; Pardiñas AF; Veronese M; Bloomfield MAP; Jauhar S; Bonoldi I; Froudist-Walsh S; Nosarti C; Korth C; Hennah W; Walters J; Prata D; Howes OD
    Hum Mol Genet; 2018 Oct; 27(20):3498-3506. PubMed ID: 29945223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
    Howes OD; Bose SK; Turkheimer F; Valli I; Egerton A; Valmaggia LR; Murray RM; McGuire P
    Am J Psychiatry; 2011 Dec; 168(12):1311-7. PubMed ID: 21768612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of treatment response in first-episode psychosis: an
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine synthesis capacity in twins discordant for schizophrenia.
    Shotbolt P; Stokes PR; Owens SF; Toulopoulou T; Picchioni MM; Bose SK; Murray RM; Howes OD
    Psychol Med; 2011 Nov; 41(11):2331-8. PubMed ID: 21426628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients.
    Katthagen T; Kaminski J; Heinz A; Buchert R; Schlagenhauf F
    Schizophr Bull; 2020 Dec; 46(6):1535-1546. PubMed ID: 32318717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-year follow-up study on the first manic episode due to mood-incongruent psychosis.
    Shi HM; Jiang DG
    Asian J Psychiatr; 2022 Jul; 73():103118. PubMed ID: 35468481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia.
    Avram M; Brandl F; Knolle F; Cabello J; Leucht C; Scherr M; Mustafa M; Koutsouleris N; Leucht S; Ziegler S; Sorg C
    Brain; 2020 Dec; 143(11):3495-3505. PubMed ID: 33155047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders.
    Cheng PWC; Chang WC; Lo GG; Chan KWS; Lee HME; Hui LMC; Suen YN; Leung YLE; Au Yeung KMP; Chen S; Mak KFH; Sham PC; Santangelo B; Veronese M; Ho CL; Chen YHE; Howes OD
    Neuropsychopharmacology; 2020 Oct; 45(11):1870-1876. PubMed ID: 32612207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Rogdaki M; Devroye C; Ciampoli M; Veronese M; Ashok AH; McCutcheon RA; Jauhar S; Bonoldi I; Gudbrandsen M; Daly E; van Amelsvoort T; Van Den Bree M; Owen MJ; Turkheimer F; Papaleo F; Howes OD
    Mol Psychiatry; 2023 May; 28(5):1995-2006. PubMed ID: 33981004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and demographic differences between patients with manic, depressive and schizophrenia-spectrum psychoses presenting to Early Intervention Services in London.
    Kapila A; Fisher HL; Johnson S; Major B; Rahaman N; Joyce J; Chamberlain-Kent N; Lawrence J; Young AH; Stone JM
    Early Interv Psychiatry; 2019 Jun; 13(3):509-516. PubMed ID: 29034588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
    Howes OD; Montgomery AJ; Asselin MC; Murray RM; Valli I; Tabraham P; Bramon-Bosch E; Valmaggia L; Johns L; Broome M; McGuire PK; Grasby PM
    Arch Gen Psychiatry; 2009 Jan; 66(1):13-20. PubMed ID: 19124684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.